Impact of Bright Light Therapy on Prader-Willi Syndrome
Part of paid clinical trials in Brooklyn, New York.
- Sponsor
- Maimonides Medical Center
- Study ID
- NCT05939453
- Status
- Recruiting
Conditions
- Behavior
- Body Weight
- Excessive Daytime Sleepiness
- Hyperphagia
- Mood
- Prader-Willi Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 88 Years
- Healthy Volunteers
- Not accepted
Interventions
- Sham Light — OTHERSham treatment will be provided from a light box at a distance of at least 70cm but no greater than 90cm.
- Bright Light Therapy — OTHERBright Light Therapy will be provided using light box with an artificial full spectrum lamp at a distance of at least 70cm but no greater than 90cm.
Study Details
This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome
Key Dates
- Start date
- Oct 1, 2023
- Status verified
- May 2026
- Primary completion
- Jun 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Sham Comparator: Sham Light
- Experimental: Light Therapy
Primary Outcome Measure
Clinical Global Impression- Improvement (CGI-I) [ Time Frame: 8 Weeks ]
Central Contacts
- Mayank Kumar, PhD718-283-8170
- Theresa Jacob, MPH, PhD718-283-7162
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Maimonides Medical Center | Brooklyn | New York | 11219 | Theresa Jacob, MPH, PhD (SUB_INVESTIGATOR) Edward Yi, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Brooklyn, NY
By research site
Related Studies
- Socialization To Enrich Participation & Support Sexuality for Young People With I/DDRecruiting · City University of New York, School of Public Health · New York, New York
- A Study of Pitolisant in Patients With Prader-Willi SyndromePHASE3 · Recruiting · Harmony Biosciences Management, Inc. · Los Angeles, California
- In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 DiabetesRecruiting · Cornell University · Brooklyn, New York
- A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of AgePHASE1 · Recruiting · Centessa Pharmaceuticals (UK) Limited · Lincoln, Nebraska